|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-5-18
|
|
pubmed:abstractText |
Previous radioimmunotherapy (RIT) clinical trials at this institution with (90)Y-labeled cT84.66 anti-CEA (carcinoembryonic antigen) evaluated the antibody conjugated to diethylenetriaminepentaacetic acid (DTPA). The aim of this phase I therapy trial was to evaluate cT84.66 conjugated to the macrocyclic chelate (90)Y-DOTA and labeled with (90)Y in a comparable patient population.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,4,7,10-tetraazacyclododecane-...,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Carcinoembryonic Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Heterocyclic Compounds, 1-Ring,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Yttrium Radioisotopes
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1084-9785
|
|
pubmed:author |
pubmed-author:ChuDavid ZDZ,
pubmed-author:FáyKK,
pubmed-author:LeongLucilleL,
pubmed-author:RaubitschekAndrew AAA,
pubmed-author:ShivelyJohn EJE,
pubmed-author:WilczynskiSharonS,
pubmed-author:WilliamsLawrence ELE,
pubmed-author:WongJeffrey Y CJY,
pubmed-author:WuAnna MAM,
pubmed-author:YamauchiDave MDM,
pubmed-author:YazakiPaul JPJ,
pubmed-author:ZhanJipingJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
88-100
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16706629-Adult,
pubmed-meshheading:16706629-Aged,
pubmed-meshheading:16706629-Antibodies, Monoclonal,
pubmed-meshheading:16706629-Carcinoembryonic Antigen,
pubmed-meshheading:16706629-Female,
pubmed-meshheading:16706629-Heterocyclic Compounds, 1-Ring,
pubmed-meshheading:16706629-Humans,
pubmed-meshheading:16706629-Immunoglobulin G,
pubmed-meshheading:16706629-Immunotoxins,
pubmed-meshheading:16706629-Male,
pubmed-meshheading:16706629-Middle Aged,
pubmed-meshheading:16706629-Neoplasm Metastasis,
pubmed-meshheading:16706629-Neoplasms,
pubmed-meshheading:16706629-Radioimmunotherapy,
pubmed-meshheading:16706629-Yttrium Radioisotopes
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
|
|
pubmed:affiliation |
City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA. JWong@coh.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase I,
Research Support, N.I.H., Extramural
|
